AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-21.09%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$700M
AUM Growth
+$700M
(-26%)
Cap. Flow
-$1.22M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
$1.79M |
Top Sells
| 1 |
Natera
NTRA
|
$3M |
| 2 |
Pulmatrix
PULM
|
$19K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $369M | 52.78% |
2,912,872
| – | – |
|
|
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
| $150M | 21.45% |
36,335,375
| – | – |
|
3
Erasca
ERAS
$445M
| $95.1M | 13.59% |
11,055,554
| – | – |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $57.3M | 8.18% |
2,508,809
| – | – |
|
|
OMIC
5
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $24M | 3.43% |
3,798,926
| – | – |
|
|
RUBY
6
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.93M | 0.28% |
349,908
| – | – |
|
|
MTCR
7
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $1.79M | 0.26% |
+2,940,503
| New | +$1.79M |
|
|
ZY
8
DELISTED
Zymergen Inc. Common Stock
ZY
| $345K | 0.05% |
119,205
| – | – |
|
|
9
Natera
NTRA
$23.1B
| – | – |
-32,098
| Closed | -$3M |
|
|
10
Pulmatrix
PULM
$18M
| – | – |
-43,639
| Closed | -$19K |
|